Delivery Order 75F40124D00023-75F40125F19002

Award Date 4/23/25
Potential Completion Date 5/29/26
Potential Value $218K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Concord, NH 03301, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the U.S. Food and Drug Administration (FDA) to the New Hampshire Liquor Commission, a U.S. state government entity. The $357,068.14 cost-no-fee contract is for the Commission to conduct tobacco retail compliance inspections, including undercover buy and advertising/labeling checks, to determine adherence to FDA regulations. Key deliverables involve recruiting and training underage purchasers, coordinating inspections, and submitting monthly...
The Food and Drug Administration (FDA) awarded a $1,174,052 delivery order to the North Carolina Department of Health and Human Services (NC DHHS) for tobacco inspection services. This order is part of a larger $19 million single-award indefinite delivery contract that allows NC DHHS to conduct tobacco retail inspections and regulatory compliance checks on behalf of the FDA across North Carolina through September 2028. The initial $1.17 million task order covers inspection services in Raleigh...
The U.S. Food and Drug Administration (FDA) awarded a $3,542,074.52 definitive contract to the State of North Carolina Department of Health and Human Services (NCDHHS) for the North Carolina Tobacco Retail Inspections program. The contract, which does not have a set-aside designation, runs through September 14, 2023. NCDHHS, the lead public health agency for the state, will leverage its expertise and state resources to support the FDA's tobacco control enforcement efforts by conducting...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $3,701,323.99 definitive cost-no-fee contract to the Massachusetts Department of Public Health (MDPH) to conduct inspections of retailers that sell and advertise regulated tobacco products and submit the inspection results to the FDA. This contract has no set-aside designation. The contract is part of a broader initiative by the FDA to partner with state agencies to support tobacco product compliance...
This is a definitive cost-no-fee contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the Department of Attorney General Maine, a U.S. state government entity, for tobacco retail inspections. The $900,436.38 contract, which runs through September 2024, supports the FDA's tobacco compliance monitoring program. Under this contract, the Department of Attorney General Maine will provide services such as recruiting and training underage purchasers,...
The U.S. Food and Drug Administration awarded a $2,531,901.07 firm-fixed-price definitive contract to the North Carolina Department of Health and Human Services (NC DHHS) to perform tobacco retail inspections and regulatory compliance services under the North Carolina State Tobacco Retail Inspection Program. This single-award indefinite delivery contract, which has a period of performance through September 2028, leverages NC DHHS's state-level authority and expertise to support the FDA's tobacco...
The Food and Drug Administration (FDA) awarded a $955,870 cost-no-fee delivery order contract to the State of North Carolina Department of Health & Human Services (NC DHHS) to obtain 2,310 units of UBS, 770 A&L's, non-inspection travel, and other direct costs to complete inspections from September 30, 2024 to September 29, 2025. This contract is part of a larger indefinite delivery vehicle (IDV) held by NC DHHS to conduct tobacco retail inspections and regulatory compliance services on...
This is a $7,372,033.08 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA) to the New Jersey Department of Health (NJDOH) to conduct inspections of retailers that sell and advertise any regulated tobacco products and submit the inspection results to the FDA. The contract has an ultimate completion date of September 29, 2025 and does not have a set-aside designation. The contract was awarded under the FDA's pre-solicitation opportunity to engage state agencies in...
This is a $5,448,968.80 definitive contract awarded by the Food and Drug Administration (FDA) to the Minnesota Department of Human Services (MN DHS) to conduct inspections of retailers that sell and advertise any regulated tobacco products and submit the inspection results to the FDA. The contract was awarded on December 20, 2020 and runs through September 29, 2025. It was awarded as a cost-no-fee contract without any set-aside designations. The contract is an outgrowth of a pre-solicitation...
The U.S. Food and Drug Administration (FDA) has awarded a $614,768.64 Indefinite Delivery Contract (IDC) task order to the State of Georgia Department of Revenue Alcohol and Tobacco Division, a state government entity. The task order, which is not set aside, covers the State of Georgia Tobacco Retail Inspection Program for the period of September 2023 to September 2024. Under this single-award IDC valued up to $11 million, the Alcohol and Tobacco Division serves as the prime contractor...
  • 75F40124D00023
    Indefinite Delivery Contract
  • 75F40124D00023-75F40125F19002
    Delivery Order

The U.S. Food and Drug Administration (FDA) awarded a $218,194.80 delivery order contract to the New Hampshire Liquor Commission (NHLC) for tobacco inspection and compliance activities in New Hampshire from May 2025 to May 2026. This is part of a larger $2,247,107.00 indefinite delivery contract between the FDA and NHLC that supports the agency's efforts to monitor and ensure compliance with tobacco regulations at the retail level. The NHLC, a state government entity, will conduct undercover compliance checks, verify advertising and labeling, and report findings to the FDA. This contract does not have a set-aside designation.

Generated 4/29/25, 10:01 AM